Research on a Quantitative Assessment of Skin Symptoms Caused by Chemotherapy Using Molecular Target Drugs
Not Applicable
- Conditions
- on-small-cell lung cancer and colorectal cancer
- Registration Number
- JPRN-UMIN000015857
- Lead Sponsor
- ational Cancer Center Hospital, Appearance Support Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have skin symptoms that influence skin functions such as atopic dermatitis. 2) Patients who receive treatments that influence skin functions such as steroids and antibacterial drugs. 3) Patients who are unable to control dependence. 4) Patients who are unable to respond to self-completed questionnaires. 5) Physicians decide it is inappropriate for the patients to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <Assessment by devices> 1) Transepidermal water loss 2) Capacitance (stratum corneum-epidermal water) 3) Erythema & melanin index 4) Visia (Facial skin condition) <Visual assessment> NCI-CTC (ver. 4.0 Japanese version JCOG) <Self-completed questionnaires> Skindex 29 (QOL regarding skin symptoms)
- Secondary Outcome Measures
Name Time Method